These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15655516)

  • 1. A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie.
    Gayrard V; Picard-Hagen N; Viguié C; Laroute V; Andréoletti O; Toutain PL
    Br J Pharmacol; 2005 Feb; 144(3):386-93. PubMed ID: 15655516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines.
    Pani A; Norfo C; Abete C; Mulas C; Putzolu M; Laconi S; Orrù CD; Cannas MD; Vascellari S; La Colla P; Dessì S
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4141-7. PubMed ID: 17709472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiprion activity of functionalized 9-aminoacridines related to quinacrine.
    Nguyen TH; Lee CY; Teruya K; Ong WY; Doh-ura K; Go ML
    Bioorg Med Chem; 2008 Jul; 16(14):6737-46. PubMed ID: 18556207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of quinacrine in the treatment of prion disease.
    Yung L; Huang Y; Lessard P; Legname G; Lin ET; Baldwin M; Prusiner SB; Ryou C; Guglielmo BJ
    BMC Infect Dis; 2004 Nov; 4():53. PubMed ID: 15569390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospects of the therapeutic approaches to Creutzfeldt-Jakob disease: a clinical trial of antimalarial, quinacrine].
    Furukawa H; Takahashi M; Nakajima M; Yamada T
    Nihon Rinsho; 2002 Aug; 60(8):1649-57. PubMed ID: 12187766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model.
    Collins SJ; Lewis V; Brazier M; Hill AF; Fletcher A; Masters CL
    Ann Neurol; 2002 Oct; 52(4):503-6. PubMed ID: 12325081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments.
    Klingenstein R; Löber S; Kujala P; Godsave S; Leliveld SR; Gmeiner P; Peters PJ; Korth C
    J Neurochem; 2006 Aug; 98(3):748-59. PubMed ID: 16749906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chimeric ligand approach leading to potent antiprion active acridine derivatives: design, synthesis, and biological investigations.
    Dollinger S; Löber S; Klingenstein R; Korth C; Gmeiner P
    J Med Chem; 2006 Nov; 49(22):6591-5. PubMed ID: 17064077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategies.
    Kocisko DA; Caughey B
    Methods Enzymol; 2006; 412():223-34. PubMed ID: 17046661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous quinacrine treatment results in the formation of drug-resistant prions.
    Ghaemmaghami S; Ahn M; Lessard P; Giles K; Legname G; DeArmond SJ; Prusiner SB
    PLoS Pathog; 2009 Nov; 5(11):e1000673. PubMed ID: 19956709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutics for prion diseases].
    Doh-ura K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):820-2. PubMed ID: 15152474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of transmitting ruminant spongiform encephalopathies (prion diseases) by semen and embryo transfer techniques.
    Wrathall AE; Holyoak GR; Parsonson IM; Simmons HA
    Theriogenology; 2008 Sep; 70(5):725-45. PubMed ID: 18586320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects.
    Haïk S; Brandel JP; Salomon D; Sazdovitch V; Delasnerie-Lauprêtre N; Laplanche JL; Faucheux BA; Soubrié C; Boher E; Belorgey C; Hauw JJ; Alpérovitch A
    Neurology; 2004 Dec; 63(12):2413-5. PubMed ID: 15623716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of quinacrine administration to patients with Creutzfeldt-Jakob disease.
    Nakajima M; Yamada T; Kusuhara T; Furukawa H; Takahashi M; Yamauchi A; Kataoka Y
    Dement Geriatr Cogn Disord; 2004; 17(3):158-63. PubMed ID: 14739538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.
    Kocisko DA; Engel AL; Harbuck K; Arnold KM; Olsen EA; Raymond LD; Vilette D; Caughey B
    Neurosci Lett; 2005 Nov; 388(2):106-11. PubMed ID: 16039063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creutzfeldt-Jakob disease acquired via a dural graft: failure of therapy with quinacrine and chlorpromazine.
    Martínez-Lage JF; Rábano A; Bermejo J; Martínez Pérez M; Guerrero MC; Contreras MA; Lunar A
    Surg Neurol; 2005 Dec; 64(6):542-5, discussion 545. PubMed ID: 16293480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial.
    Collinge J; Gorham M; Hudson F; Kennedy A; Keogh G; Pal S; Rossor M; Rudge P; Siddique D; Spyer M; Thomas D; Walker S; Webb T; Wroe S; Darbyshire J
    Lancet Neurol; 2009 Apr; 8(4):334-44. PubMed ID: 19278902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin treatment prolongs the survival of scrapie-infected mice.
    Kempster S; Bate C; Williams A
    Neuroreport; 2007 Mar; 18(5):479-82. PubMed ID: 17496807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased GH secretion in scrapie, a prion-associated neurodegenerative disease, is not due to suppressed IGF-1 negative feedback.
    Viguié C; Picard-Hagen N; Gayrard V; Toutain PL
    Domest Anim Endocrinol; 2009 Apr; 36(3):127-37. PubMed ID: 19179038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell culture models to unravel prion protein function and aberrancies in prion diseases.
    Bedecs K
    Methods Mol Biol; 2008; 459():1-20. PubMed ID: 18576144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.